SOX2 and p63 colocalize at genetic loci in squamous cell carcinomas-Reference-Cited by-同舟云学术

SOX2 and p63 colocalize at genetic loci in squamous cell carcinomas

Published:2014-03-03 Issue:4 Volume:124 Page:1636-1645
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:J. Clin. Invest.

Author:

Watanabe Hideo,Ma Qiuping,Peng Shouyong,Adelmant Guillaume,Swain Danielle,Song Wenyu,Fox Cameron,Francis Joshua M.,Pedamallu Chandra Sekhar,DeLuca David S.,Brooks Angela N.,Wang Su,Que Jianwen,Rustgi Anil K.,Wong Kwok-kin,Ligon Keith L.,Liu X. Shirley,Marto Jarrod A.,Meyerson Matthew,Bass Adam J.

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference57 articles.

1. Annual Report to the Nation on the Status of Cancer, 1975–2009, Featuring the Burden and Trends in Human Papillomavirus (HPV)–Associated Cancers and HPV Vaccination Coverage Levels

2. SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas

3. SOX2 identified as a target gene for the amplification at 3q26 that is frequently detected in esophageal squamous cell carcinoma

4. SOX2 Is an Oncogene Activated by Recurrent 3q26.3 Amplifications in Human Lung Squamous Cell Carcinomas

5. SOX2 amplification is a common event in squamous cell carcinomas of different organ sites

Cited by 138 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patterns of Aneuploidy and Signaling Consequences in Cancer;Cancer Research;2024-06-26

2. A druggable cascade links methionine metabolism to epigenomic reprogramming in squamous cell carcinoma;Proceedings of the National Academy of Sciences;2024-06-20

3. Pathogenic role of super-enhancers as potential therapeutic targets in lung cancer;Frontiers in Pharmacology;2024-04-12

4. The molecular and cellular choreography of early mammalian lung development;Medical Review;2024-03-26

5. Reciprocal inhibition between TP63 and STAT1 regulates anti-tumor immune response through interferon-γ signaling in squamous cancer;Nature Communications;2024-03-20